Advanced search
Add to list

Neoadjuvant chemotherapy with bevacizumab may improve outcome following cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis

Wim Ceelen (UGent) and Piet Pattyn (UGent)
(2014) ANNALS OF SURGICAL ONCOLOGY. 21(suppl. 1). p.S85-S85
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Ceelen, Wim, and Piet Pattyn. “Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome Following Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal Carcinomatosis.” Annals of Surgical Oncology. Vol. 21. 2014. S85–S85. Print.
APA
Ceelen, Wim, & Pattyn, P. (2014). Neoadjuvant chemotherapy with bevacizumab may improve outcome following cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis. ANNALS OF SURGICAL ONCOLOGY (Vol. 21, pp. S85–S85). Presented at the 67th Annual Cancer symposium of the Society of Surgical Oncology.
Chicago author-date
Ceelen, Wim, and Piet Pattyn. 2014. “Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome Following Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal Carcinomatosis.” In Annals of Surgical Oncology, 21:S85–S85.
Chicago author-date (all authors)
Ceelen, Wim, and Piet Pattyn. 2014. “Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome Following Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal Carcinomatosis.” In Annals of Surgical Oncology, 21:S85–S85.
Vancouver
1.
Ceelen W, Pattyn P. Neoadjuvant chemotherapy with bevacizumab may improve outcome following cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis. ANNALS OF SURGICAL ONCOLOGY. 2014. p. S85–S85.
IEEE
[1]
W. Ceelen and P. Pattyn, “Neoadjuvant chemotherapy with bevacizumab may improve outcome following cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis,” in ANNALS OF SURGICAL ONCOLOGY, Phoenix, AZ, USA, 2014, vol. 21, no. suppl. 1, pp. S85–S85.
@inproceedings{5709649,
  author       = {Ceelen, Wim and Pattyn, Piet},
  booktitle    = {ANNALS OF SURGICAL ONCOLOGY},
  issn         = {1068-9265},
  language     = {eng},
  location     = {Phoenix, AZ, USA},
  number       = {suppl. 1},
  pages        = {S85--S85},
  title        = {Neoadjuvant chemotherapy with bevacizumab may improve outcome following cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis},
  volume       = {21},
  year         = {2014},
}

Web of Science
Times cited: